IBD Patients with Iron Deficiency Treated Intravenously Had More Clinical, Cost Benefits, Study Finds

IBD Patients with Iron Deficiency Treated Intravenously Had More Clinical, Cost Benefits, Study Finds
Researchers found that patients with inflammatory bowel disease (IBD) with iron deficiency (ID) or iron deficiency anemia (IDA) who were administered iron intravenously were hospitalized less frequently and had lower total healthcare costs compared to patients who took iron orally. The study, "Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis," was published in the journal ClinicoEconomics and Outcomes Re
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *